{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:32:30Z","timestamp":1782862350208,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jaip.2015.03.001","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T13:19:46Z","timestamp":1428412786000},"page":"711-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"3","author":[{"given":"Von","family":"Ta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2015.03.001_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2500\/aap.2012.33.3541","article-title":"Aspirin-exacerbated respiratory disease: burden of disease","volume":"33","author":"Chang","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2015.03.001_bib2","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2015.03.001_bib6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJM199012273232618","article-title":"Shortness of (fresh) breath\u2013toothpaste-induced bronchospasm","volume":"323","author":"Spurlock","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0091-6749(92)90478-K","article-title":"Toothpaste flavor-induced asthma","volume":"90","author":"Subiza","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","article-title":"Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease","volume":"119","author":"Lee","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.iac.2012.10.002","article-title":"Aspirin-exacerbated respiratory disease: clinical disease and diagnosis","volume":"33","author":"Bochenek","year":"2013","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2015.03.001_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/CRIAI:24:2:189","article-title":"Prevention and treatment of reactions to NSAIDs","volume":"24","author":"Simon","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","article-title":"The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions","volume":"32","author":"Berges-Gimeno","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2015.03.001_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1081-1206(10)62575-6","article-title":"Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics","volume":"85","author":"Stevenson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","article-title":"Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Dahlen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib16","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-27","article-title":"Treatment of aspirin-intolerant asthma with antileukotrienes","volume":"161","author":"Dahlen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.1996.03530360041036","article-title":"Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial. Zileuton Clinical Trial Group","volume":"275","author":"Israel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2015.03.001_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1081-1206(10)62432-5","article-title":"Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics","volume":"85","author":"Pauls","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2015.03.001_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2007.09.036","article-title":"Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis","volume":"121","author":"Grundmann","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib23","first-page":"448","article-title":"Omalizumab: a potential new therapeutic approach for aspirin-exacerbated respiratory disease","volume":"20","author":"Bobolea","year":"2010","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.aller.2012.02.005","article-title":"Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease","volume":"41","author":"Aksu","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2015.03.001_bib25","first-page":"158","article-title":"Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab","volume":"19","author":"Guglielmo","year":"2009","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/a0017502","article-title":"Sense of smell disorder and health-related quality of life","volume":"54","author":"Smeets","year":"2009","journal-title":"Rehabil Psychol"},{"key":"10.1016\/j.jaip.2015.03.001_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/lary.21387","article-title":"Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia","volume":"121","author":"Neuland","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2015.03.001_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaip.2014.05.003","article-title":"RE: Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Payne","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2015.03.001_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0954-6111(96)90300-5","article-title":"Menthol and aspirin-induced asthma","volume":"90","author":"Kawane","year":"1996","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJM199105233242119","article-title":"Toothpaste-induced bronchospasm","volume":"324","author":"Kawane","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2015.03.001_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.jaip.2015.03.001_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4196\/kjpp.2010.14.6.419","article-title":"Functional expression of TRPV4 cation channels in human mast cell line (HMC-1)","volume":"14","author":"Kim","year":"2010","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.jaip.2015.03.001_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fimmu.2012.00150","article-title":"The role of TRP proteins in mast cells","volume":"3","author":"Freichel","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0906-6705.2004.0178.x","article-title":"Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures","volume":"13","author":"Stander","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2015.03.001_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1471-4159.2006.04192.x","article-title":"Ethanol inhibits cold-menthol receptor TRPM8 by modulating its interaction with membrane phosphatidylinositol 4,5-bisphosphate","volume":"100","author":"Benedikt","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jaip.2015.03.001_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157015908783769644","article-title":"Herbal compounds and toxins modulating TRP channels","volume":"6","author":"Vriens","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jaip.2015.03.001_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1081-1206(10)63086-4","article-title":"Effect of cow milk on pulmonary function in atopic asthmatic patients","volume":"79","author":"Nguyen","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0091-6749(98)70192-7","article-title":"Do dairy products induce bronchoconstriction in adults with asthma?","volume":"101","author":"Woods","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2015.03.001_bib39","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/mnfr.201000408","article-title":"A\u00a0systematic review of salicylates in foods: estimated daily intake of a Scottish population","volume":"55","author":"Wood","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jaip.2015.03.001_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1398-9995.1980.tb01731.x","article-title":"Sodium salicylate and aspirin disease","volume":"35","author":"Dahl","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2015.03.001_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0194599814555836","article-title":"Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study","volume":"152","author":"Sommer","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2015.03.001_bib42","first-page":"23","article-title":"A\u00a0low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5","volume":"69","author":"Kragballe","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2015.03.001_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219815001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219815001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:08:31Z","timestamp":1761973711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219815001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213219815001208"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2015.03.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2015.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}